Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.

Adsay, N V; Dergham, S T; Koppitch, F C; Dugan, M C; Mohamed, A N; Vaitkevicius, V K; Sarkar, F H

Adsay, N V; Dergham, S T; Koppitch, F C; Dugan, M C; Mohamed, A N; Vaitkevicius, V K; Sarkar, F H.

Affiliation

Adsay NV; Department of Pathology, Wayne State University School of Medicine, Harper Hospital, and Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

Pancreas ; 18(2): 111-6, 1999 Mar.

Article in En | MEDLINE | ID: mdl-10090407

Subject(s)

Adenocarcinoma/diagnosis; In Situ Hybridization, Fluorescence; Pancreatic Ducts/pathology; Pancreatic Neoplasms/diagnosis; Adenocarcinoma/genetics; Adenocarcinoma/pathology; Chromosome Deletion; Chromosomes, Human/genetics; Gene Dosage; Genes, myc/genetics; Genes, p53/genetics; Humans; Immunohistochemistry; Pancreatic Neoplasms/genetics; Pancreatic Neoplasms/pathology; Polyploidy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Ducts / Pancreatic Neoplasms / Adenocarcinoma / In Situ Hybridization, Fluorescence Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pancreas Year: 1999 Document type: Article

Search on Google

XML

PubMed Links